SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Enliven Therapeutics, Inc.
@ELVN_InsiderForm 4 Filing: Collins Helen Louise Sells $275,773.384 of $ELVN
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Enliven Therapeutics, Inc.
Ticker: $ELVN
Transaction Value
$275,773.384
Price/Share: $27.58
transaction date
2026-07-17
Shares: 10,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Collins Helen Louise, holds the title of CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc..
On 2026-07-17, the insider transacted 10,000 shares.The shares were transacted at a weighted average price of $27.58 per share, resulting in a total market-relevant value of $275,773.384.
Executive Summary Summary
Collins Helen Louise (CHIEF MEDICAL OFFICER) sold $276K of $ELVN
Post-Transaction Position: 25,063 shares
SEC Accession No: 0001701247-26-000011 (CIK: 1701247)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.